Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Capital Expenditures (2017 - 2025)

Historic Capital Expenditures for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to $4233.0.

  • Selectis Health's Capital Expenditures rose 76661.42% to $4233.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $396824.0, marking a year-over-year increase of 131012.76%. This contributed to the annual value of $36063.0 for FY2024, which is 2099.65% up from last year.
  • Per Selectis Health's latest filing, its Capital Expenditures stood at $4233.0 for Q3 2025, which was up 76661.42% from $163515.0 recorded in Q2 2025.
  • Selectis Health's Capital Expenditures' 5-year high stood at $239679.0 during Q3 2022, with a 5-year trough of -$108408.0 in Q4 2022.
  • Over the past 5 years, Selectis Health's median Capital Expenditures value was $34706.5 (recorded in 2022), while the average stood at $66377.3.
  • As far as peak fluctuations go, Selectis Health's Capital Expenditures plummeted by 51879.01% in 2022, and later soared by 76661.42% in 2025.
  • Quarter analysis of 5 years shows Selectis Health's Capital Expenditures stood at $25886.0 in 2021, then crashed by 518.79% to -$108408.0 in 2022, then skyrocketed by 101.77% to $1914.0 in 2023, then skyrocketed by 413.9% to $9836.0 in 2024, then plummeted by 56.96% to $4233.0 in 2025.
  • Its Capital Expenditures stands at $4233.0 for Q3 2025, versus $163515.0 for Q2 2025 and $219240.0 for Q1 2025.